Renal impairment and glucose management in type 2 diabetes
You need to login to participate in this education.
This education is accredited: RACGP 2 CPD, ACRRM 1 CME PD.
Type 2 diabetes is a serious health issue with around one million diagnosed cases, of which half are also affected from renal impairment. This education module explores the pharmacological and non-pharamacological management of type 2 diabetes and its comorbities, with a focus on management options in patients with renal impairment.
Upon completion of this learning module, participants will be able to:
- Appreciate the increased complexity of managing type 2 diabetes resulting from frequent physical and mental comorbidities
- Be aware of the impact of renal impairment on people with type 2 diabetes, and understand the implications for treatment, including glucose-lowering therapies
- Know the dose reduction requirements of DPP-4 inhibitors in people with type 2 diabetes and renal impairment, and the evidence regarding incorrect dosing and patient non-adherence.
This activity is sponsored by Boehringer Ingelheim.
|Renal impairment and glucose management in type 2 diabetes - education|
|Renal impairment and glucose management in type 2 diabetes - evaluation|